Proceedings From the Global Cardio-Oncology Summit: The Top 10 Priorities to Actualize for CardioOncology.
CV, cardiovascular
CVD, cardiovascular disease
DOAC, direct oral anticoagulant
GCOS, Global Cardio-Oncology Summit
GLS, global longitudinal strain
HCT, hematopoietic cell transplantation
ICI, immune checkpoint inhibitor
LVEF, left ventricular ejection fraction
PD-1, programmed cell death 1 or its ligand
PD-L1, programmed cell death ligand 1
TKI, tyrosine kinase inhibitor
VTE, venous thromboembolism
anthracycline
antiangiogenic therapy
bone marrow transplantation
breast cancer
cancer survivorship
immunotherapy
thrombosis
tyrosine kinase inhibitor
Journal
JACC. CardioOncology
ISSN: 2666-0873
Titre abrégé: JACC CardioOncol
Pays: United States
ID NLM: 101761697
Informations de publication
Date de publication:
Dec 2019
Dec 2019
Historique:
received:
22
10
2019
accepted:
04
11
2019
entrez:
16
8
2021
pubmed:
17
12
2019
medline:
17
12
2019
Statut:
epublish
Résumé
The discipline of cardio-oncology has expanded at a remarkable pace. Recent developments and challenges to clinicians who practice cardio-oncology were presented at the Global Cardio-Oncology Summit on October 3 to 4, 2019, in São Paulo, Brazil. Here, we present the top 10 priorities for our field that were discussed at the meeting, and also detail a potential path forward to address these challenges. Defining robust predictors of cardiotoxicity, clarifying the role of cardioprotection, managing and preventing thromboembolism, improving hematopoietic stem cell transplant outcomes, personalizing cardiac interventions, building the cardio-oncology community, detecting and treating cardiovascular events associated with immunotherapy, understanding tyrosine kinase inhibitor cardiotoxicity, and enhancing survivorship care are all priorities for the field. The path forward requires a commitment to research, education, and excellence in clinical care to improve our patients' lives.
Identifiants
pubmed: 34396188
doi: 10.1016/j.jaccao.2019.11.007
pii: S2666-0873(19)30092-4
pmc: PMC8352295
doi:
Types de publication
Journal Article
Review
Langues
eng
Pagination
256-272Informations de copyright
© 2019 The Authors.
Références
J Am Coll Cardiol. 2018 Apr 24;71(16):1755-1764
pubmed: 29567210
Ann Oncol. 2018 Jan 1;29(1):284-286
pubmed: 29106493
J Am Coll Cardiol. 2018 Aug 7;72(6):697-698
pubmed: 30072003
J Am Coll Cardiol. 2014 Mar 4;63(8):809-16
pubmed: 24291281
Eur Heart J Acute Cardiovasc Care. 2018 Oct;7(7):631-638
pubmed: 28593789
Circulation. 2017 Apr 11;135(15):1397-1412
pubmed: 28104715
Blood. 2019 Apr 4;133(14):1597-1606
pubmed: 30692122
Lancet. 2018 Nov 10;392(10159):1736-1788
pubmed: 30496103
Thromb Res. 2018 Apr;164 Suppl 1:S23-S28
pubmed: 29703480
Bone Marrow Transplant. 2014 Oct;49(10):1330-6
pubmed: 25068429
Circ Cardiovasc Interv. 2016 Jun;9(6):
pubmed: 27313281
J Glob Oncol. 2015 Nov 25;1(2):73-82
pubmed: 28804776
Circulation. 2015 Jun 2;131(22):1981-8
pubmed: 25948538
J Clin Oncol. 2018 Jul 10;36(20):2017-2023
pubmed: 29746227
J Clin Oncol. 2015 Dec 10;33(35):4210-8
pubmed: 26371140
Blood. 2007 Nov 15;110(10):3784-92
pubmed: 17671231
Ann Intern Med. 2014 Jan 7;160(1):11-7
pubmed: 24573662
Blood. 2010 Oct 28;116(17):3129-39; quiz 3377
pubmed: 20656930
Blood Adv. 2017 Sep 08;1(20):1739-1748
pubmed: 29296820
Prog Cardiovasc Dis. 2010 Sep-Oct;53(2):88-93
pubmed: 20728695
Ann Oncol. 2011 Sep;22 Suppl 6:vi85-92
pubmed: 21908511
J Clin Oncol. 2011 Jun 1;29(16):2230-9
pubmed: 21464398
Biol Blood Marrow Transplant. 2009 Apr;15(4):416-20
pubmed: 19285628
J Clin Oncol. 2017 Mar 10;35(8):870-877
pubmed: 27893331
J Am Coll Cardiol. 2013 Jan 8;61(1):77-84
pubmed: 23199515
J Clin Oncol. 2012 Dec 20;30(36):4458-61
pubmed: 23045598
JAMA Cardiol. 2019 Oct 1;4(10):1007-1018
pubmed: 31433450
J Immunother Cancer. 2017 Nov 21;5(1):91
pubmed: 29157297
J Am Coll Cardiol. 2019 Oct 1;74(13):1667-1678
pubmed: 31558250
Oncologist. 2018 Aug;23(8):874-878
pubmed: 29802220
Catheter Cardiovasc Interv. 2016 Apr;87(5):E202-23
pubmed: 26756277
Circulation. 2016 Mar 15;133(11):1104-14
pubmed: 26976915
J Clin Oncol. 2018 Jun 10;36(17):1714-1768
pubmed: 29442540
J Clin Oncol. 2018 Oct 20;36(30):2980-2987
pubmed: 29791284
J Clin Oncol. 2020 Feb 10;38(5):496-520
pubmed: 31381464
Cancer. 2014 Feb 15;120(4):469-79
pubmed: 24166350
Clin Lymphoma Myeloma Leuk. 2017 Dec;17(12):870-878.e1
pubmed: 28803825
Clin Cancer Res. 2011 May 15;17(10):3490-9
pubmed: 21372222
Thromb Haemost. 2017 Oct 5;117(10):1952-1961
pubmed: 28837207
Circulation. 2006 Dec 5;114(23):2474-81
pubmed: 17101852
N Engl J Med. 2019 Feb 21;380(8):720-728
pubmed: 30786186
N Engl J Med. 2019 Feb 21;380(8):711-719
pubmed: 30511879
N Engl J Med. 2016 Nov 03;375(18):1749-1755
pubmed: 27806233
Ann Oncol. 2002 May;13(5):710-5
pubmed: 12075738
J Am Coll Cardiol. 2019 Jan 22;73(2):248-249
pubmed: 30654897
J Clin Oncol. 2017 Mar 10;35(8):893-911
pubmed: 27918725
Circulation. 2004 Jun 8;109(22):2749-54
pubmed: 15148277
Trends Cardiovasc Med. 2019 Jan;29(1):29-39
pubmed: 29910109
JACC Clin Electrophysiol. 2018 Dec;4(12):1491-1500
pubmed: 30573111
Tumour Biol. 2016 Mar;37(3):3379-87
pubmed: 26449821
J Clin Oncol. 2008 Dec 1;26(34):5537-43
pubmed: 18809605
JACC CardioOncol. 2019 Jun 15;1(1):131-132
pubmed: 34396170
Eur Heart J. 2016 Jun 1;37(21):1671-80
pubmed: 26903532
Arch Intern Med. 2006 Feb 27;166(4):458-64
pubmed: 16505267
J Immunother Cancer. 2019 Feb 22;7(1):53
pubmed: 30795818
J Am Coll Cardiol. 2010 Dec 14;56(25):e50-103
pubmed: 21144964
N Engl J Med. 2018 Feb 15;378(7):615-624
pubmed: 29231094
J Clin Oncol. 2012 Nov 1;30(31):3792-9
pubmed: 22987084
N Engl J Med. 2018 May 10;378(19):1789-1801
pubmed: 29658430
Cardiovasc Toxicol. 2017 Oct;17(4):487-493
pubmed: 28861837
Am J Cardiol. 2019 Aug 15;124(4):539-544
pubmed: 31208701
Catheter Cardiovasc Interv. 2020 Jul;96(1):53-63
pubmed: 31410970
J Oncol Pract. 2018 Oct;14(10):580-587
pubmed: 30312560
N Engl J Med. 2005 Jul 14;353(2):172-87
pubmed: 16014887
Nat Rev Cardiol. 2019 Apr;16(4):243-256
pubmed: 30518952
Hematology Am Soc Hematol Educ Program. 2002;:422-44
pubmed: 12446435
Eur J Cancer. 2016 Nov;68:11-21
pubmed: 27693889
J Clin Invest. 2007 Oct;117(10):2974-82
pubmed: 17853943
J Card Fail. 2016 Jun;22(6):465-71
pubmed: 27038642
Blood. 2012 Nov 29;120(23):4505-12
pubmed: 23034279
Circulation. 2017 Nov 21;136(21):2085-2087
pubmed: 29158217
J Immunother Cancer. 2017 Nov 21;5(1):95
pubmed: 29162153
Blood. 2014 Dec 18;124(26):3991-5
pubmed: 25305202
J Am Coll Cardiol. 2017 Aug 22;70(8):926-938
pubmed: 28818202
Curr Probl Cancer. 2018 Jul;42(4):375-385
pubmed: 30126650
N Engl J Med. 2017 Jul 13;377(2):111-121
pubmed: 28636844
N Engl J Med. 2015 Nov 19;373(21):2038-47
pubmed: 26466021
Curr Oncol Rep. 2018 Apr 11;20(6):45
pubmed: 29644475
JAMA Oncol. 2016 May 01;2(5):625-632
pubmed: 26847662
J Am Heart Assoc. 2014 Feb 28;3(1):e000472
pubmed: 24584736
J Am Soc Echocardiogr. 2014 Sep;27(9):911-39
pubmed: 25172399
Leukemia. 2017 Nov;31(11):2388-2397
pubmed: 28757617
Ann Surg. 2016 Aug;264(2):244-51
pubmed: 26764872
Blood. 2005 Jun 1;105(11):4215-22
pubmed: 15701723
N Engl J Med. 2014 Dec 4;371(23):2155-66
pubmed: 25399658
JACC Cardiovasc Imaging. 2018 Aug;11(8):1098-1105
pubmed: 29909105
PLoS One. 2014 May 06;9(5):e96736
pubmed: 24800827
Oncologist. 2019 May;24(5):e196-e197
pubmed: 30910868
Hypertension. 2018 Feb;71(2):e1-e8
pubmed: 29279311
Circ Cardiovasc Imaging. 2012 Sep 1;5(5):596-603
pubmed: 22744937
J Clin Oncol. 2015 May 10;33(14):1592-600
pubmed: 25847925
Curr Treat Options Cardiovasc Med. 2019 Jun 15;21(7):34
pubmed: 31203459
J Clin Oncol. 2019 Aug 1;37(22):1946-1955
pubmed: 31188726
J Am Coll Cardiol. 2019 Jun 11;73(22):2859-2868
pubmed: 31171092
Blood. 2013 Sep 5;122(10):1712-23
pubmed: 23908465
Cancer Med. 2016 Apr;5(4):617-22
pubmed: 26823131
Ann Intern Med. 2011 Jul 5;155(1):21-32
pubmed: 21727290
Lancet. 2019 Sep 21;394(10203):1041-1054
pubmed: 31443926
J Clin Oncol. 2007 Sep 1;25(25):3991-4008
pubmed: 17577017
JAMA Oncol. 2016 Aug 1;2(8):1030-7
pubmed: 27348762
J Clin Oncol. 2016 Jan 20;34(3):235-43
pubmed: 26573075
Science. 2018 Mar 23;359(6382):1350-1355
pubmed: 29567705
J Am Coll Cardiol. 2000 Aug;36(2):517-22
pubmed: 10933366
JACC CardioOncol. 2019 Sep;1(1):54-65
pubmed: 33083790
N Engl J Med. 2019 Sep 26;381(13):1268-1277
pubmed: 31553841
Am J Cardiol. 2019 Oct 15;124(8):1190-1197
pubmed: 31395298
Eur Heart J. 2019 Dec 21;40(48):3913-3920
pubmed: 31318428
J Am Coll Cardiol. 2018 May 22;71(20):2281-2290
pubmed: 29540327
J Card Fail. 2016 Jun;22(6):433-8
pubmed: 27079675
Cardiol Rev. 2005 Mar-Apr;13(2):80-6
pubmed: 15705258
J Natl Cancer Inst. 2019 Aug 1;111(8):837-844
pubmed: 30951603
Ann Oncol. 2018 Jan 1;29(1):84-91
pubmed: 29228097
Mayo Clin Proc. 2016 Dec;91(12):1680-1692
pubmed: 27916154
Curr Oncol. 2017 Oct;24(5):e348-e353
pubmed: 29089804
Circulation. 2019 May 21;139(21):e997-e1012
pubmed: 30955352
Am J Cardiol. 2001 Feb 15;87(4):459-62, A6
pubmed: 11179536
Ann Oncol. 2017 Jul 1;28(suppl_4):iv119-iv142
pubmed: 28881921
Breast Cancer Res Treat. 2012 Jul;134(1):291-8
pubmed: 22476854
Lancet. 2002 Jun 15;359(9323):2078-83
pubmed: 12086762
Biol Blood Marrow Transplant. 2015 May;21(5):799-808
pubmed: 25445027
N Engl J Med. 2013 Mar 14;368(11):987-98
pubmed: 23484825
Bone Marrow Transplant. 2012 May;47(5):619-25
pubmed: 21643022